THE FINANCIAL EXPRESS

December 23, 2004

Cipla, Avesthagen expand programme scope

Cipla and Bangalore based Avesthagen have expanded the scope of their ongoing biotherapeutics development programme. The expanded pipeline includes innovative next generation drugs that cater to the oncology and cardiovascular segments.